1. Bhat, Neha, Narayanan, Anand, Fathzadeh, Mohsen, Abou Ziki, Maen D, Mani, Arya. 2021. Dyrk1b promotes autophagy during skeletal muscle differentiation by upregulating 4e-bp1. In Cellular signalling, 90, 110186. doi:10.1016/j.cellsig.2021.110186. https://pubmed.ncbi.nlm.nih.gov/34752933/
2. Friedman, Eileen. . Mirk/Dyrk1B in cancer. In Journal of cellular biochemistry, 102, 274-9. doi:. https://pubmed.ncbi.nlm.nih.gov/17583556/
3. Dong, Chao, West, Kirk L, Tan, Xin Yi, Leung, Justin W C, Huen, Michael S Y. 2020. Screen identifies DYRK1B network as mediator of transcription repression on damaged chromatin. In Proceedings of the National Academy of Sciences of the United States of America, 117, 17019-17030. doi:10.1073/pnas.2002193117. https://pubmed.ncbi.nlm.nih.gov/32611815/
4. Becker, Walter. 2017. A wake-up call to quiescent cancer cells - potential use of DYRK1B inhibitors in cancer therapy. In The FEBS journal, 285, 1203-1211. doi:10.1111/febs.14347. https://pubmed.ncbi.nlm.nih.gov/29193696/
5. Dong, Chao, An, Liwei, Yu, Cheng-Han, Huen, Michael S Y. . A DYRK1B-dependent pathway suppresses rDNA transcription in response to DNA damage. In Nucleic acids research, 49, 1485-1496. doi:10.1093/nar/gkaa1290. https://pubmed.ncbi.nlm.nih.gov/33469661/
6. Chen, Yingying, Wang, Shuo, He, Zhixian, Wang, Yingying, Cheng, Chun. 2017. Dyrk1B overexpression is associated with breast cancer growth and a poor prognosis. In Human pathology, 66, 48-58. doi:10.1016/j.humpath.2017.02.033. https://pubmed.ncbi.nlm.nih.gov/28554575/
7. Abu Jhaisha, Samira, Widowati, Esti W, Kii, Isao, Papadopoulos, Chrisovalantis, Becker, Walter. 2017. DYRK1B mutations associated with metabolic syndrome impair the chaperone-dependent maturation of the kinase domain. In Scientific reports, 7, 6420. doi:10.1038/s41598-017-06874-w. https://pubmed.ncbi.nlm.nih.gov/28743892/
智鼠故事 
